Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers

Who May Qualify: 1. Have a suspected or proven sigmoid colon adenocarcinoma 2. Is eligible for curative treatment 3. Has no irresectable metastatic disease 4. MRI can be reviewed by an MDT prior to surgery 5. Has no decision regarding radical treatment 6. Have provided written willing to sign a consent form to participate in the study 7. Be aged 16 years or over Who Should NOT Join This Trial: 1. Have metastatic disease (including resectable liver metastases) 2. Have a synchronous second malignancy 3. Are contraindicated for MRI 4. Are contraindicated for or have allergy to Buscopan (e.g. glaucoma, small or large bowel obstruction, GFR\<30) 5. Have severe co-morbidities or previous medical history that prevent the application of eventual chemo/radiotherapy Always talk to your doctor about whether this trial is right for you.